146 related articles for article (PubMed ID: 1863141)
1. Cardiac transplantation with corticosteroid-free immunosuppression: long-term results.
Lee KF; Pierce JD; Hess ML; Hastillo AK; Wechsler AS; Guerraty AJ
Ann Thorac Surg; 1991 Aug; 52(2):211-7; discussion 218. PubMed ID: 1863141
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
3. Individualized immunosuppression in heart transplant recipients.
Haverich A; Frimpong-Boateng K; Schäfers HJ; Wahlers T; Fieguth HG; Herrmann G; Wonigeit K; Borst HG
Transplant Proc; 1987 Feb; 19(1 Pt 3):2514-5. PubMed ID: 3274552
[No Abstract] [Full Text] [Related]
4. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
5. Benefits of avoidance of induction immunosuppression in heart transplantation.
Menkis AH; McKenzie FN; Thomson D; Jones M; Pflugfelder P; Kostuk WJ; Stiller CR
J Heart Transplant; 1989; 8(4):311-4. PubMed ID: 2671316
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
7. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
Wrenshall LE; Matas AJ; Canafax DM; Min DI; Sibley RJ; Dunn DL; Payne WD; Sutherland DE; Najarian JS
Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291
[TBL] [Abstract][Full Text] [Related]
8. Heart transplantation in Paris, at "La Pitie" Hospital.
Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P
J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522
[No Abstract] [Full Text] [Related]
9. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
Swenson JM; Fricker FJ; Armitage JM
J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
[TBL] [Abstract][Full Text] [Related]
11. Acute cardiac ongoing rejection: comparison between different strategies.
Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
[No Abstract] [Full Text] [Related]
12. [Antilymphocytic sera versus azathioprine, combined with cyclosporin and steroids, in liver transplant. Comparison of the results at the intensive care unit and 2 years' follow-up].
Cisneros Alonso C; Díaz Castellanos MA; Montero Castilló A; Moreno González E; Calleja González J; Gómez Gutiérrez M; Sánchez-Izquierdo Riera JA; García Fuentes C
Rev Clin Esp; 1990 Feb; 186(2):68-73. PubMed ID: 2330440
[TBL] [Abstract][Full Text] [Related]
13. Clinical results of steroid-free induction immunosuppression after heart transplantation.
Livi U; Luciani GB; Boffa GM; Faggian G; Bortolotti U; Thiene G; Mazzucco A
Ann Thorac Surg; 1993 May; 55(5):1160-5. PubMed ID: 8494426
[TBL] [Abstract][Full Text] [Related]
14. Low dose ciclosporin from the early postoperative period yields potent immunosuppression after renal transplantation.
Brady HR; Kamel KS; Harding ME; Cook GT; deVeber GA; Cardella CJ
Nephron; 1990; 55(4):394-9. PubMed ID: 2202920
[TBL] [Abstract][Full Text] [Related]
15. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
16. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
Renlund DG; Bristow MR; Crandall BG; Burton NA; Doty DB; Karwande SV; Gay WA; Jones KW; Hegewald MG; Hagan ME
J Heart Transplant; 1989; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
[TBL] [Abstract][Full Text] [Related]
17. Optimalization of immunosuppression after xenogeneic heart transplantation in primates.
Reichenspurner H; Human PA; Boehm DH; Rose AG; May R; Cooper DK; Zilla P; Reichart B
J Heart Transplant; 1989; 8(3):200-7; discussion 207-8. PubMed ID: 2661769
[TBL] [Abstract][Full Text] [Related]
18. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
[TBL] [Abstract][Full Text] [Related]
20. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
